SPM Corp. (Vietnam)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000SPM9
VND
10,500.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 2.19% of over the last 5 years

 
2

The company declared positive results in Dec'24 after very negative results in Sep'24

3

With ROE of 2.31%, it has a very attractive valuation with a 0.18 Price to Book Value

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND 144,585 Million (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.76%

stock-summary
Debt Equity

0.12

stock-summary
Return on Equity

2.31%

stock-summary
Price to Book

0.18

Revenue and Profits:
Net Sales:
82,515 Million
(Quarterly Results - Mar 2025)
Net Profit:
3,149 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.78%
0%
-2.78%
6 Months
-7.49%
0%
-7.49%
1 Year
-7.08%
0%
-7.08%
2 Years
-4.55%
0%
-4.55%
3 Years
-29.05%
0%
-29.05%
4 Years
-48.78%
0%
-48.78%
5 Years
-20.45%
0%
-20.45%

SPM Corp. (Vietnam) for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-10.91%
EBIT Growth (5y)
2.19%
EBIT to Interest (avg)
3.04
Debt to EBITDA (avg)
4.34
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.41
Tax Ratio
11.23%
Dividend Payout Ratio
149.08%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.32%
ROE (avg)
2.02%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.18
EV to EBIT
8.28
EV to EBITDA
4.94
EV to Capital Employed
0.27
EV to Sales
0.81
PEG Ratio
0.08
Dividend Yield
4.76%
ROCE (Latest)
3.22%
ROE (Latest)
2.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 12.79% vs -0.71% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -69.03% vs 730.47% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "82,515.40",
          "val2": "73,157.70",
          "chgp": "12.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10,666.90",
          "val2": "16,207.80",
          "chgp": "-34.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,575.00",
          "val2": "1,726.70",
          "chgp": "-8.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,148.60",
          "val2": "10,166.60",
          "chgp": "-69.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "69.30%",
          "val2": "155.00%",
          "chgp": "-8.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -26.68% vs -41.76% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -61.89% vs -49.29% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "297,775.00",
          "val2": "406,104.90",
          "chgp": "-26.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28,068.80",
          "val2": "42,470.20",
          "chgp": "-33.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7,446.80",
          "val2": "11,761.30",
          "chgp": "-36.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,618.20",
          "val2": "12,116.70",
          "chgp": "-61.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.20%",
          "val2": "75.10%",
          "chgp": "-3.69%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
82,515.40
73,157.70
12.79%
Operating Profit (PBDIT) excl Other Income
10,666.90
16,207.80
-34.19%
Interest
1,575.00
1,726.70
-8.79%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3,148.60
10,166.60
-69.03%
Operating Profit Margin (Excl OI)
69.30%
155.00%
-8.57%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is 12.79% vs -0.71% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is -69.03% vs 730.47% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
297,775.00
406,104.90
-26.68%
Operating Profit (PBDIT) excl Other Income
28,068.80
42,470.20
-33.91%
Interest
7,446.80
11,761.30
-36.68%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4,618.20
12,116.70
-61.89%
Operating Profit Margin (Excl OI)
38.20%
75.10%
-3.69%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -26.68% vs -41.76% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -61.89% vs -49.29% in Dec 2023

stock-summaryCompany CV
About SPM Corp. (Vietnam) stock-summary
stock-summary
SPM Corp. (Vietnam)
Pharmaceuticals & Biotechnology
S.P.M Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and imports multivitamin and mineral supplements, tonic and natural products, functional food, as well as various other kinds of drugs. It is engaged in the trading of drugs to domestic market and overseas markets, such as the United States, Myanmar and Malaysia. Its products are distributed solely by Do Thanh Pharmaceutical Company Limited. The Company also trades medical equipment and supplies. In addition, it provides offices, spaces and warehouses for rent.
Company Coordinates stock-summary
Company Details
Lo 51, Duong so 2, KCN Tan Tao, Q. Binh Tan HO CHI MINH None : None
stock-summary
Tel: 84 8 38771003
stock-summary
Registrar Details